Matthew J. Mimiaga is Adjunct Professor of Epidemiology and Behavioral & Social Sciences at Brown University. His primary appointment is as tenured Full Professor and Vice Chair of Epidemiology at UCLA Fielding School of Public Health and Psychiatry & Biobehavioral Sciences at UCLA David Geffen School of Medicine, Los Angeles, CA. He is Director of the UCLA Center for LGBTQ+ Advocacy, Research & Health (C- LARAH) and affiliated Senior Research Scientist at The Fenway Institute, Fenway Health, Boston, MA.
Previous Academic Appointments. Before joining UCLA in 2020, Dr. Mimiaga was tenured Professor of Epidemiology and Behavioral & Social Health Sciences (School of Public Health) and Professor of Psychiatry & Human Behavior (Alpert Medical School) at Brown University, Providence, RI (from 2015 – 2020). Prior to his appointment at Brown University, he was Professor of Epidemiology at Harvard T.H. Chan School of Public Health and Professor of Psychiatry at Harvard Medical School, Boston, MA (from 2008 – 2015).
Education & Training. Dr. Mimiaga completed the Postdoctoral Research Fellowship Training Program in Behavioral Medicine, Department of Psychiatry, Harvard Medical School; he received a Doctorate of Science from Harvard University, a Master of Public Health from Boston University, and a Master of Arts from Brown University.
Scholarship & Editorial Activities. To date, Dr. Mimiaga has authored over 385 peer-reviewed, original scientific journal articles in the areas of infectious disease/HIV epidemiology, mental health, substance use and public health, including numerous book chapters and commentaries. Dr. Mimiaga is Deputy Editor for the Journal of the International AIDS Society (JIAS); Academic Editor for PLOS ONE; Senior Associate Editor for Annals of LGBTQ Public and Population Health; and currently on the editorial boards of 8 scientific journals (e.g., PLOS ONE, AIDS Care, Transgender Health, JIAS).
Mimiaga's PUBMED page & Google Scholar profile
Research Funding as PI. Dr. Mimiaga is / has been the principal investigator (PI) of several federally-, state- and foundation-funded research grants. These include 21 National Institutes of Health (NIH)-funded R- and U-level grants (7 R01s, 1 R56, 6 R34s, 4 R21s, 1 R03, and 2 U01s), 2 Centers for Disease Control and Prevention (CDC)-funded U01 grants, 1 ATN and 1 HPTN NIH-supported network grants, and greater than 35 additional research grants via MA and RI State Departments of Public Health, private foundations (e.g., amfAR), the Center For AIDS Research (CFAR) at UCLA, Harvard and Brown, Harvard Catalyst Grant Program, The Watson Institute, Brown Seed Award Program, the Reagan Institute of MGH, MIT and Harvard, the James B. Pendleton Charitable Trust, NIH administrative and diversity supplements, and other university supported funding opportunities.
I have had several opportunities to participate in the National Institutes of Health funded biomedical clinical trials networks and large cohort studies as an investigator and member of protocol development committees, including: HIV Prevention Trials Network (HPTN063, HPTN061), HIV Vaccine Trials Network (HVTN505), Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN 170), Center for AIDS Research Network of Integrated Clinical Systems CNICS, and the MACS/WIHS Combined Cohort Study (MWCCS).
Mimiaga's Active NIH Funded Grants as PI
Primary Mentor on Funded Research. Dr. Mimiaga is / has been the primary mentor on more than 30 NIH pre- and post-doctoral training grants (e.g., R36, NRSA, K-, and T32 awards); CFAR developmental awards; NIH diversity supplements; UCLA graduate student summer grants; UCLA HEALRISE / EDI Fellowship Grants; Robert Wood Johnson Foundation Health Policy Fellowship grants; and an NIH COBRE award.
Links:
Active NIH Funded Grants as PI
